Status:
COMPLETED
Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine
Lead Sponsor:
Pfizer
Conditions:
Vaccines, Pneumococcal
Eligibility:
All Genders
42-98 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of the 13-valent pneumococcal vaccine (13vPnC) compare to the 7-valent pneumococcal vaccine (7vPnC) and to compare...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy 2-month-old infants.
- Available for the entire study period.
- Exclusion criteria:
- Previous vaccination with any vaccine before the start of the study.
- Known contraindication to vaccination.
Exclusion
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
666 Patients enrolled
Trial Details
Trial ID
NCT00373958
Start Date
September 1 2006
End Date
June 1 2008
Last Update
February 21 2013
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Fayetteville, Arkansas, United States, 72703
2
Jonesboro, Arkansas, United States, 72401
3
Little Rock, Arkansas, United States, 72205
4
Downey, California, United States, 90242